Advertisement
Screener

Vivani Medical, Inc. (VANI) Selling and Marketing Expense

1.4 / 5 stars · 14/50 Roast Me

Vivani Medical, Inc. Selling and Marketing Expense

Vivani Medical, Inc. (VANI) reported Selling and Marketing Expense of $701.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-29.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SellingAndMarketingExpense · last filed 2022-03-29

  • Vivani Medical, Inc. selling and marketing expense for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
  • Vivani Medical, Inc. selling and marketing expense for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
  • Vivani Medical, Inc. selling and marketing expense for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
  • Vivani Medical, Inc. selling and marketing expense for the quarter ending 2020-03-31 was $701.00K, a 66.67% decline year-over-year.
  • Vivani Medical, Inc. selling and marketing expense for fiscal 2020 was $701.00K, a 88.51% decline from fiscal 2019.
  • Vivani Medical, Inc. selling and marketing expense for fiscal 2019 was $6.10M, a 46.18% decline from fiscal 2018.
  • Vivani Medical, Inc. selling and marketing expense for fiscal 2018 was $11.34M, a 18.47% increase from fiscal 2017.
  • Vivani Medical, Inc. selling and marketing expense for fiscal 2017 was $9.57M, a 6.45% increase from fiscal 2016.
Period endSelling and Marketing Expense 3 monthSelling and Marketing Expense 3 month as first filedSelling and Marketing Expense 6 monthSelling and Marketing Expense 6 month as first filedSelling and Marketing Expense 9 monthSelling and Marketing Expense 9 month as first filedSelling and Marketing Expense 12 month
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$0.00
derived: sum of 2 quarters · filed 2022-03-29
$0.00
derived: sum of 3 quarters · filed 2022-03-29
$701.00K
10-K · filed 2022-03-29
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$0.00
derived: sum of 2 quarters · filed 2021-11-12
$701.00K
10-Q · filed 2021-11-12
$1.70M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13
$701.00K
10-Q · filed 2021-08-13
$1.70M
derived: sum of 3 quarters · filed 2021-08-13
$3.01M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31$701.00K
10-Q · filed 2021-05-13
$1.70M
derived: sum of 2 quarters · filed 2021-05-13
$3.01M
derived: sum of 3 quarters · filed 2021-05-13
$4.70M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
$2.31M
derived: sum of 2 quarters · filed 2021-03-16
$4.00M
derived: sum of 3 quarters · filed 2021-03-16
$6.10M
10-K · filed 2021-03-16
2019-09-30$1.31M
10-Q · filed 2020-11-12
$3.00M
derived: sum of 2 quarters · filed 2020-11-12
$5.10M
10-Q · filed 2020-11-12
$7.50M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$1.69M
10-Q · filed 2020-08-13
$3.79M
10-Q · filed 2020-08-13
$6.20M
derived: sum of 3 quarters · filed 2020-08-13
$9.24M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$2.10M
10-Q · filed 2020-06-26
$4.51M
derived: sum of 2 quarters · filed 2020-06-26
$7.55M
derived: sum of 3 quarters · filed 2020-06-26
$10.43M
derived: sum of 4 quarters · filed 2020-06-26
2018-12-31$2.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19
$5.45M
derived: sum of 2 quarters · filed 2020-03-19
$8.32M
derived: sum of 3 quarters · filed 2020-03-19
$11.34M
10-K · filed 2020-03-19
2018-09-30$3.04M
10-Q · filed 2019-11-14
$5.92M
derived: sum of 2 quarters · filed 2019-11-14
$8.93M
10-Q · filed 2019-11-14
$11.44M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$2.88M
10-Q · filed 2019-08-06
$5.89M
10-Q · filed 2019-08-06
$8.40M
derived: sum of 3 quarters · filed 2019-08-06
$10.78M
derived: sum of 4 quarters · filed 2019-08-06
2018-03-31$3.01M
10-Q · filed 2019-05-15
$5.52M
derived: sum of 2 quarters · filed 2019-05-15
$7.90M
derived: sum of 3 quarters · filed 2019-05-15
$10.35M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$2.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19
$4.89M
derived: sum of 2 quarters · filed 2019-03-19
$7.33M
derived: sum of 3 quarters · filed 2019-03-19
$9.57M
10-K · filed 2019-03-19
2017-09-30$2.38M
10-Q · filed 2018-11-08
$4.82M
derived: sum of 2 quarters · filed 2018-11-08
$7.06M
10-Q · filed 2018-11-08
$9.57M
derived: sum of 4 quarters · filed 2019-03-19
2017-06-30$2.45M
10-Q · filed 2018-08-07
$4.68M
10-Q · filed 2018-08-07
$7.20M
derived: sum of 3 quarters · filed 2019-03-19
$9.46M
derived: sum of 4 quarters · filed 2019-03-19
2017-03-31$2.23M
10-Q · filed 2018-05-15
$4.75M
derived: sum of 2 quarters · filed 2019-03-19
$7.01M
derived: sum of 3 quarters · filed 2019-03-19
$9.21M
derived: sum of 4 quarters · filed 2019-03-19
2016-12-31$2.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19
$4.78M
derived: sum of 2 quarters · filed 2019-03-19
$6.98M
derived: sum of 3 quarters · filed 2019-03-19
$8.99M
10-K · filed 2019-03-19
2016-09-30$2.26M
10-Q · filed 2017-11-06
$4.46M
derived: sum of 2 quarters · filed 2017-11-06
$6.47M
10-Q · filed 2017-11-06
$8.98M
derived: sum of 4 quarters · filed 2018-03-20
2016-06-30$2.20M
10-Q · filed 2017-08-07
$4.21M
10-Q · filed 2017-08-07
$6.72M
derived: sum of 3 quarters · filed 2018-03-20
$8.85M
derived: sum of 4 quarters · filed 2018-03-20
2016-03-31$2.01M
10-Q · filed 2017-05-09
$2.01K
10-Q · filed 2016-05-06
$4.52M
derived: sum of 2 quarters · filed 2018-03-20
$6.65M
derived: sum of 3 quarters · filed 2018-03-20
$8.95M
derived: sum of 4 quarters · filed 2018-03-20
2015-12-31$2.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20
$4.64M
derived: sum of 2 quarters · filed 2018-03-20
$6.94M
derived: sum of 3 quarters · filed 2018-03-20
$8.94M
10-K · filed 2018-03-20
2015-09-30$2.13M
10-Q · filed 2016-11-04
$2.13M
10-Q · filed 2015-11-16
$4.43M
derived: sum of 2 quarters · filed 2016-11-04
$6.42M
10-Q · filed 2016-11-04
$6.43M
10-Q · filed 2015-11-16
$6.59M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$2.30M
10-Q · filed 2016-08-08
$2.30M
10-Q · filed 2015-08-05
$4.29M
10-Q · filed 2016-08-08
$4.29M
10-Q · filed 2015-08-05
$4.45M
derived: sum of 3 quarters · filed 2017-03-16
$6.06M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$2.00K
10-Q · filed 2016-05-06
$1.99M
10-Q · filed 2015-05-15
$2.16M
derived: sum of 2 quarters · filed 2017-03-16
$3.76M
derived: sum of 3 quarters · filed 2017-03-16
$5.59M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$2.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$3.76M
derived: sum of 2 quarters · filed 2017-03-16
$5.59M
derived: sum of 3 quarters · filed 2017-03-16
$6.84M
10-K · filed 2017-03-16
2014-09-30$1.61M
10-Q · filed 2015-11-16
$3.44M
derived: sum of 2 quarters · filed 2015-11-16
$4.69M
10-Q · filed 2015-11-16
2014-06-30$1.83M
10-Q · filed 2015-08-05
$3.08M
10-Q · filed 2015-08-05
2014-03-31$1.25M
10-Q · filed 2015-05-15
2013-12-31$3.30M
10-K · filed 2016-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Streamex Corp. (STEX)United States$0.089B-0.19
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
EDAP TMS SA (FOCL)$0.171B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
IRIDEX CORP (IRIX)United States$0.011B